- Exchange: Frankfurt
- Sector: Health Care
- Industry: Medical Equipment & Devices
- Sub-Industry: Medical Equipment
Cerus Corp+ Add to Watchlist
CU2:GR3.818 EUR 0.001 0.03%
As of 10:04:48 ET on 03/27/2015.
Company Profile for Cerus Corp (CU2)
Cerus Corporation develops systems designed to enhance the safety of blood transfusions. The Company's systems inactivate pathogens in blood components and inactivate white blood cells, which are responsible for a variety of adverse transfusion reactions. Cerus' platform technologies prevent viral, bacterial, and cellular replication.
Key Executives for Cerus Corp (CU2)
|William Mariner Greenman "Obi"President/CEO||Chrystal N MenardChief Legal Officer|
|Caspar HogeboomPres:Cerus Europe||Laurence M CorashSenior VP/Chief Medical Ofcr/Co-Founder|
|Carol M MooreSenior VP:Regulatory Affairs||Kevin D GreenVP:Finance/CFO|
|Lori L RollSecretary|